Nrc Health (NRC) Net Income towards Common Stockholders (2010 - 2026)

Nrc Health has disclosed Net Income towards Common Stockholders across 17 years of filings, most recently posting $3.2 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $3.2 million, down 44.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (up 206.56% YoY), and the FY2025 annual result was $11.6 million, up 246.71% from the prior year.
• Net Income towards Common Stockholders came in at $3.2 million for Q1 2026 at Nrc Health, up from $1.8 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $8.5 million in Q1 2022 to a low of -$31.2 million in Q4 2023.
• The 5-year median for Net Income towards Common Stockholders is $5.8 million (2025), against an average of -$295882.4.
• Across the five-year window, Net Income towards Common Stockholders plunged 391.12% in 2022 and surged 106.88% in 2025, its largest moves.
• Nrc Health's Net Income towards Common Stockholders stood at -$28.0 million in 2022, then slipped by 11.16% to -$31.2 million in 2023, then advanced by 16.18% to -$26.1 million in 2024, then soared by 106.88% to $1.8 million in 2025, then soared by 79.2% to $3.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $3.2 million (Q1 2026), $1.8 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.